BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 2712917)

  • 1. Profile of an oxytocin antagonist, RWJ 22164 for treatment of preterm labor in laboratory models of uterine contractility.
    Demarest KT; Hahn DW; Ericson E; Capetola RJ; Fuchs AR; McGuire JL
    Am J Perinatol; 1989 Apr; 6(2):200-4. PubMed ID: 2712917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 1-deamino-[D-Tyr(Oethyl)2, Thr4, Orn8] vasotocin, an oxytocin antagonist, in animal models of uterine contractility and preterm labor: a new tocolytic agent.
    Hahn DW; Demarest KT; Ericson E; Homm RE; Capetola RJ; McGuire JL
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):977-82. PubMed ID: 3674173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin receptor blockade: a new principle in the treatment of preterm labor?
    Andersen LF; Lyndrup J; Akerlund M; Melin P
    Am J Perinatol; 1989 Apr; 6(2):196-9. PubMed ID: 2540760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin antagonist (dTVT) and oxytocin receptors in myometrium and decidua.
    Fuchs AR; Vangsted A; Ivanisevic M; Demarest K
    Am J Perinatol; 1989 Apr; 6(2):205-8. PubMed ID: 2540761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barusiban suppresses oxytocin-induced preterm labour in non-human primates.
    Reinheimer TM
    BMC Pregnancy Childbirth; 2007 Jun; 7 Suppl 1(Suppl 1):S15. PubMed ID: 17570159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxytocin antagonist (dTVT) and ritodrine on spontaneous and oxytocics-induced uterine contractions in pregnant rats.
    Chimura T
    Asia Oceania J Obstet Gynaecol; 1991 Sep; 17(3):265-70. PubMed ID: 1953439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
    Serradeil-Le Gal C; Valette G; Foulon L; Germain G; Advenier C; Naline E; Bardou M; Martinolle JP; Pouzet B; Raufaste D; Garcia C; Double-Cazanave E; Pauly M; Pascal M; Barbier A; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2004 Apr; 309(1):414-24. PubMed ID: 14722330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of stimulatory and inhibitory drugs on uterine electrical activity measured noninvasively from the abdominal surface of pregnant rats.
    Buhimschi CS; Saade GR; Buhimschi IA; Gokdeniz R; Boyle MB; Garfield RE
    Am J Obstet Gynecol; 2000 Jul; 183(1):68-75. PubMed ID: 10920311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
    Akerlund M; Melin P; Maggi M
    Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor.
    Chan WY; Hruby VJ; Rockway TW; Hlavacek J
    J Pharmacol Exp Ther; 1986 Oct; 239(1):84-7. PubMed ID: 3761199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review on prostaglandin and oxytocin activity in preterm labor.
    Ivanisević M; Djelmis J; Buković D
    Coll Antropol; 2001 Dec; 25(2):687-94. PubMed ID: 11811300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women.
    Pierzynski P; Lemancewicz A; Reinheimer T; Akerlund M; Laudanski T
    J Soc Gynecol Investig; 2004 Sep; 11(6):384-7. PubMed ID: 15350251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
    Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.
    Goodwin TM; Millar L; North L; Abrams LS; Weglein RC; Holland ML
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):913-7. PubMed ID: 7573268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-phenoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agonist for the treatment of preterm labor.
    Croci T; Cecchi R; Marini P; Rouget C; Viviani N; Germain G; Guagnini F; Fradin Y; Descamps L; Pascal M; Advenier C; Breuiller-Fouché M; Leroy MJ; Bardou M
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1118-26. PubMed ID: 17351104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new tocolytic agent: development of an oxytocin antagonist for inhibiting uterine contractions.
    Wilson L; Parsons MT; Ouano L; Flouret G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):195-202. PubMed ID: 2375344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban.
    Bossmar T; Akerlund M; Fantoni G; Szamatowicz J; Melin P; Maggi M
    Am J Obstet Gynecol; 1994 Dec; 171(6):1634-42. PubMed ID: 7802081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.